Short Description Oisin Bio founder developing suicide‑gene senolytics.
Description Serial entrepreneur Matt Scholz co‑invented a transposon‑based gene‑therapy that delivers apoptotic genes under p16 promoters to delete senescent cells in vivo. Oisin’s pre‑clinical work shows robust lifespan extension in mice with minimal off‑target toxicity. Scholz open‑sources the ‘Longevity Discord’ community and invests in moonshot biotechnology via OnDeck Longevity Fellowship.